Adma Biologics (ADMA) Change in Inventory (2011 - 2025)

Adma Biologics has reported Change in Inventory for 13 years, with the latest figure at $9.8 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Inventory rose 725.67% year-over-year to $9.8 million; the trailing twelve-month figure through Dec 2025 stood at $36.2 million (up 1456.42% YoY), and the FY2025 full-year result was $36.2 million, up 1456.42% from the prior year.
• Change in Inventory for Q4 2025 stood at $9.8 million, up from $5.2 million in the prior quarter.
• The five-year high for Change in Inventory was $19.3 million in Q2 2025, with the low at -$8.0 million in Q3 2024.
• Historically, Change in Inventory has averaged $6.2 million across 5 years, with a median of $5.4 million in 2021.
• Annual changes were most pronounced in 2023 — Change in Inventory soared 2571.53% — and 2024, when it tumbled 699.48%.
• Adma Biologics' Change in Inventory stood at $10.6 million in 2021, then tumbled by 96.54% to $366457.0 in 2022, then soared by 2571.53% to $9.8 million in 2023, then plunged by 116.0% to -$1.6 million in 2024, then surged by 725.67% to $9.8 million in 2025.
• The last three Change in Inventory figures came in at $9.8 million (Q4 2025), $5.2 million (Q3 2025), and $19.3 million (Q2 2025), per Business Quant data.